Priming to mycobacterial antigen in vivo using antigen-pulsed antigen presenting cells generated in vitro is influenced by the dose and presence of IL-4 in APC cultures

Scandinavian Journal of Immunology

Volumn 46, Issue 1, 1997, Pages 1-9

  Dillon, S M ^a   Hart, D N J ^b   Abernethy, N ^c   Watson, J D ^c   Baird, M A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Genesis Research & Development Corporation Ltd   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOBACTERIUM ANTIGEN;

ANIMAL CELL; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CONTROLLED STUDY; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030792085     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-88.x     Document Type: Article

References (46)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
2. Koch F, Trockenbacher B, Kämpgen E et al Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells. J Immunol 1995;155:93-100.
3. Romani N, Koide S, Crowley M et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 1989;169:1169-78.
4. Pure E, Inaba K, Crowley M et al. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex Class 2 molecules and expression of invariant chain. J Exp Med 1990;172:1459-69.
5. Romani N, Lenz A, Glassel H et al. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol 1989;93:600-9
6. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985;161:526-46.
7. Teunissen MBM, Wormmeester J, Krieg SR et al. Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture. J Invest Dermatol 1990;94:166-73.
8. Inaba K, Witmer Pack M, Inaba M et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180: 1849-60.
9. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med 1992;176:1215-20.
10. Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony stimulating factor. J Exp Med 1992;176:1693-902.
11. Inaba K, Steinman RM, Witmer-Pack M et al. Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 1992;175:1157-67.
12. Lu L, Woo J, Rao AS et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of Type-1 collagen. J Exp Med 1944;179:1823-34.
13. Lu L, Hsich M, Oriss TB et al. Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses. Immunol 1995;84:127-34.
14. Caux C, Massacrier C, Dezutter-Dambuyant C et al. Human dendritic Langerhans cells generated in vitro from CD4+ progenitors can prime naive CD4+ T cells and process soluble antigen. J Immunol 1995;155:5427-33.
15. Flamand V, Sornasse T, Thielemans K et al. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 1994;24:605-10.
16. Hsu FJ, Benike C, Fagnoni, F et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 1996;2:52-8.
17. Mayordomo JI, Zorina T, Storkus WJ et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med 1995;1:1297-302.
18. Scheicher C, Mehlig M, Zecher R, Reske K. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J Immunol Meth 1992;154:253-64.
19. Porgador A, Gilboa E. Bone marrow-generated dendritic cells pulsed with a Class 1-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 1995;182:255-60.
20. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109-18
21. Romani N, Gruner S, Brang D. Proliferating dendritic cell progenitors in human blood J Exp Med 1994;180:83-93.
22. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cold blood stem cells into dendritic cells and macrophages. J Leukoc Biol 1992;52:274-81.
23. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-61.
24. Santiago-Schwartz F, Ruppa DA, Laky K, Carsons SE. Stem cell factor augments tumour necrosis factor granulocyte macrophage colony stimulating factor-mediated dendritic cell hematopoiesis. Stem Cells 1995;136:186-97.
25. Jansen JH, Wientjens G-JHM, Fibbe WE, Willemze R, Kluin-Nelemans HC. Inhibition of human macrophage colony formation by interleukin 4. J Exp Med 1989;170:577-82.
26. Julius MH, Simpson E, Herzenberg LA. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 1973;3:645-9.
27. Baird MA, Hart DNJ, Abernethy N, Watson JD. Dendritic cell presentation of PPD and 19 kDa protein of Mycobacterium tuberculosis and emergent T helper cell phenotype. Immunol Cell Biol 1995;73:537-43.
28. Vremec D, Zorbas M, Scollay R et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med 1992;176:47-58.
29. Grainger R, Hart DNJ, Watson JD, Baird MA. Antigen-pulsed, interleukin-4-treated B cells activate primed T cells in vitro but not naive T cells in vivo. Scand J Immunol 1995;42:517-23.
30. Stack RM, Lenschow DJ, Gray GS, Bluestone JA, Fitch FW. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J Immunol 1994;152:5723-33.
31. Kawamura T, Furue M. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. Eur J Immunol 1995;25:1913-17.
32. Freeman GJ, Boussiotis VA, Anumanthan A et al. B7-1 and B7-2 do not deliver identical costimulatory signals since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995;2:523-32.
33. Lenschow DJ, Ho SC, Sattar H et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995;181: 1145-55.
34. Kuchroo VK, Das MP, Brown J et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 1995;80: 707-18.
35. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
36. Jiang W, Swiggard WJ, Heufler C et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995;375:151-5.
37. Nair S, Buiting AMJ, Rouse RJD, Van Rooijen N, Huang L, Rouse BT. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int Immunol 1995;7:679-88.
38. Gong JL, McCarthy KM, Rogers RA, Schneeberger EE. Interstitial lung macrophages interact with dendritic cells to present antigenic peptides derived from particulate antigens to T cells. Immunol 1994;81:343-51.
39. Pancholi P, Mirza A, Schauf V, Steinman RM, Bhardwaj N. Presentation of mycobacterial antigens by human dendritic cells: lack of transfer from infected macrophages. Infect Immun 1993;61: 5326-32.
40. Rider BJ, Fraga E, Yu Q, Singh B. Immune responses to self peptides naturally presented by murine Class 2 major histocompatibility complex molecules. Mol Immunol 1996;33:625-33.
41. MacKay CR. T cell memory: the connection between function, phenotype and migration pathways. Immunol Today 1991;12:189-92.
42. Romani N, Reider D, Heuer M et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996; 196:137-151.
43. Hinrich Peters J, Gieseler R, Thele B, Steinbach F. Dendritic cells: from ontogenetic orphans to myelomonocytic descendents. Immunol Today 1996;17:273-8.
44. Zitvogel L, Majordomo JI, Tjandrawan T et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells. B7 costimulation and T helper cell 1-associated cytokines. J Exp Med 1996;183:87-97.
45. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 1996;183:283-7.
46. Young JW, Inaba K. Dendritic cells as adjuvants for Class 1 major histocompatibility complex-restricted antitumor immunity. J Exp Med 1996;183:7-11.